Search

Author/Creator Xu, Fang‐Ping

1. High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer. Issue 19 (6th September 2021)

Authors:
Feng, Hui‐Bo; Chen, Yu; Xie, Zhi; Jiang, Jie; Zhong, Yu‐Min; Guo, Wei‐Bang; Yan, Wen‐Qing; Lv, Zhi‐Yi; Lu, Dan‐Xia; Liang, Hong‐Ling; Xu, Fang‐Ping; Yang, Jin‐Ji; Yang, Xue‐Ning; Zhou, Qing; Zhang, Dong‐Kun; Zhang, Zhou; Chuai, Shao‐Kun; Zhang, Heng‐Hui; Wu, Yi‐Long; Zhang, Xu‐Chao
Journal:
Thoracic cancer
Issue:
Volume 12:Issue 19(2021)
Page Start:
2564
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Overexpression of SRC‐3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness. (26th October 2016)

Authors:
Xu, Fang‐Ping; Liu, Yan‐Hui; Luo, Xin‐Lan; Zhang, Fen; Zhou, Hai‐Yu; Ge, Yan; Liu, Chao; Chen, Jie; Luo, Dong‐Lan; Yan, Li‐Xu; Mei, Ping; Xu, Jie; Zhuang, Heng‐Guo
Journal:
Cancer medicine
Issue:
Volume 5:Number 12(2016:Dec.)
Page Start:
3500
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search